Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial

Max S. Topp, MD, Nicola Goekbuget, MD, Gerhard Zugmaier, MD, Andreas Viardot, MD, Matthias Stelljes, Svenja Neumann, MD, Heinz A. Horst, MD, Albrecht Reichle, MD, Reinhard E Marks, MD, Monika Brueggemann, MD, Matthias Ritgen, MD, Petra Klappers, Noemi Mergen, MD, Marie-Elisabeth Goebeler, MD, Hermann Einsele, Dieter Hoelzer, MD, Ralf Bargou, MD

Blood (2011) 118 (21): 252.

https://doi.org/10.1182/blood.V118.21.252.252

Published: 2011

Journal Articles

Everolimus and Mycophenolate as GvHD Prophylaxis Results In Improved Control of Advanced Disease and Reduced Bacterial and Fungal Infectious Complications After Allogeneic Stem Cell Transplantation

Reinhard E Marks, Hartmut Bertz, Ralph M. Waesch, MD, Wolfgang Melchinger, Juergen Finke

Blood (2010) 116 (21): 1264.

https://doi.org/10.1182/blood.V116.21.1264.1264

Published: 2010

Journal Articles

Pulmonary Graft-Versus-Host Disease After Reduced Toxicity Conditioning with Fludarabin, Carmustine and Melphalan Prior to Hematopoietic Stem Cell Transplantation

Jesus Duque-Afonso, Antje Prasse, Ralph Wäsch, Hartmut Bertz, Jurgen Finke, MD, Reinhard E Marks

Blood (2010) 116 (21): 1266.

https://doi.org/10.1182/blood.V116.21.1266.1266

Published: 2010

Journal Articles

Everolimus Enhances Immunomodulation of Alloreative T Cells by Multipotent Stromal Cells Due to Transforming Growth Factor - β Dependent Mechanisms

Razvan George Racila, Wolfgang Melchinger, Jürgen Finke, MD, Reinhard E Marks

Blood (2010) 116 (21): 2545.

https://doi.org/10.1182/blood.V116.21.2545.2545

Published: 2010

Journal Articles

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level

Reinhard E. Marks, Allen W. Ho, Christian Robbel, Todd Kuna, Seth Berk, Thomas F. Gajewski

Blood (2007) 110 (6): 1982–1988.

https://doi.org/10.1182/blood-2006-06-031088

Published: 2007

NARROW

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial

Everolimus and Mycophenolate as GvHD Prophylaxis Results In Improved Control of Advanced Disease and Reduced Bacterial and Fungal Infectious Complications After Allogeneic Stem Cell Transplantation

Pulmonary Graft-Versus-Host Disease After Reduced Toxicity Conditioning with Fludarabin, Carmustine and Melphalan Prior to Hematopoietic Stem Cell Transplantation

Everolimus Enhances Immunomodulation of Alloreative T Cells by Multipotent Stromal Cells Due to Transforming Growth Factor - β Dependent Mechanisms

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level

Email alerts

ASH Publications

American Society of Hematology

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial

Everolimus and Mycophenolate as GvHD Prophylaxis Results In Improved Control of Advanced Disease and Reduced Bacterial and Fungal Infectious Complications After Allogeneic Stem Cell Transplantation

Pulmonary Graft-Versus-Host Disease After Reduced Toxicity Conditioning with Fludarabin, Carmustine and Melphalan Prior to Hematopoietic Stem Cell Transplantation

Everolimus Enhances Immunomodulation of Alloreative T Cells by Multipotent Stromal Cells Due to Transforming Growth Factor - β Dependent Mechanisms

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only